New Anti-Ageing Therapy Extends Lifespan of Mice by 25%, Reduces Cancer

Jul 18, 2024, 01:06 AM

A new anti-ageing therapy has been shown to extend the lifespan of mice by nearly 25%, according to a study published in Nature. The therapy involves inhibiting interleukin-11 (IL-11), a pro-inflammatory cytokine, which leads to significant health benefits and increased longevity in mice. Both genetic deletion and an anti-IL-11 drug were effective in extending the lifespan of male mice by 22.5% and female mice by 25%. The treated mice, dubbed 'supermodel grannies' due to their youthful appearance, were healthier, stronger, and had fewer age-related health problems. The therapy also reduced the incidence of cancer. This breakthrough has raised hopes for similar anti-ageing treatments in humans, with the anti-IL-11 antibody already in early clinical trials for other conditions such as lung fibrosis.